Matches in Nanopublications for { ?s ?p "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_assertion description "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_assertion description "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion description "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_provenance.
- NP310747.RAlxbURik6kNM0pGp-r11ZxXk43nMTl_idFd6K4HjjulU130_assertion description "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310747.RAlxbURik6kNM0pGp-r11ZxXk43nMTl_idFd6K4HjjulU130_provenance.